Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Pozycja w akcjach #32454
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Cena akcji
$0.04367217
Ostatnia synchronizacja: 2026-08-17
Kapitalizacja rynkowa
$10.06M
Zmiana (1 dzień)
3.99%
Zmiana (1 rok)
-26.77%
Kraj
SE
Handel IDL Diagnostics AB (publ) (IDLDX)

Kategoria

Historia ceny akcji dla IDL Diagnostics AB (publ) (IDLDX)
Najwyższa cena zamknięcia: $0.04 dnia 2026-08-01

Najniższa cena zamknięcia: $0.66 dnia 2011-05-01
Historia cen akcji firmy IDL Diagnostics AB (publ) od 2011 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 6.57%
2025 9.67%
2024 -12.09%
2023 -20.98%
2022 -57.24%
2021 -56.70%
2020 105.13%
2019 -47.78%
2018 -46.79%
2017 -31.41%
2016 -39.64%
2015 56.69%
2014 -37.92%
2013 65.83%
2012 40.59%
2011 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$586.41 20.28%
US
$202.37 -3.18%
US
$24.18 79.18%
CN
$314.26 95.01%
US
$544.68 -14.61%
US